Caplacizumab Therapy in Immune Thrombotic Thrombocytopenic Purpura

被引:0
作者
Reti, Marienn [1 ]
Sinkovits, Gyorgy [2 ]
Varkonyi, Andrea [1 ]
Kiraly, Agnes [1 ]
Farkas, Zita [1 ]
Bogsch, Luca [1 ]
Icleanu, Andreea-Adela [2 ]
Masszi, Tamas [2 ]
Valyi-Nagy, Istvan [1 ]
Prohaszka, Zoltan [2 ]
Remenyi, Peter Pal [1 ]
机构
[1] Cent Hosp Southern Pest, Natl Inst Hematol & Infect Dis, Dept Hematol & Stem Cell Transplantat, Budapest, Hungary
[2] Semmelweis Univ, Eotvos Lorand Res Network, Off Supported Res Grp, Dept Internal Med & Hematol, Budapest, Hungary
关键词
D O I
10.1182/blood-2023-186633
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
[41]   Thrombotic thrombocytopenic purpura in caplacizumab era-An individualized approach [J].
Sarode, Ravi .
TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (02)
[42]   A critical evaluation of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura [J].
Gomez-Segui, Ines ;
Fernandez-Zarzoso, Miguel ;
de la Rubia, Javier .
EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (11) :1153-1164
[43]   Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use [J].
Hannah A. Blair ;
Katherine A. Lyseng-Williamson .
Drugs & Therapy Perspectives, 2019, 35 :263-270
[44]   Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial) [J].
Estcourt, L. J. .
TRANSFUSION MEDICINE, 2019, 29 (03) :146-148
[45]   ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy [J].
Mingot-Castellano, Maria-Eva ;
Garcia-Candel, Faustino ;
Martinez-Nieto, Jorge ;
Garcia-Arroba, Jose ;
de la Rubia-Comos, Javier ;
Gomez-Segui, Ines ;
Paciello-Coronel, Maria-Liz ;
Valcarcel-Ferreiras, David ;
Jimenez, Moraima ;
Cid, Joan ;
Lozano, Miquel ;
Garcia-Gala, Jose-Maria ;
Angos-Vazquez, Sonia ;
Vara-Pampliega, Miriam ;
Guerra-Dominguez, Luisa ;
Avila-Idrobo, Laura-Francisca ;
Oliva-Hernandez, Ana ;
Zalba-Marcos, Saioa ;
Tallon-Ruiz, Inmaculada ;
Ortega-Sanchez, Sandra ;
Goterris-Viciedo, Rosa ;
Moreno-Jimenez, Gemma ;
Dominguez-Acosta, Lourdes ;
Araiz-Ramirez, Maria ;
Hernandez-Mateos, Luis ;
Flores-Ballesteros, Elena ;
del Rio-Garma, Julio ;
Pascual-Izquierdo, Cristina .
BLOOD, 2024, 143 (18) :1807-1815
[47]   Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use [J].
Blair, Hannah A. ;
Lyseng-Williamson, Katherine A. .
DRUGS & THERAPY PERSPECTIVES, 2019, 35 (06) :263-270
[48]   Immune-mediated thrombotic thrombocytopenic purpura in childhood treated by caplacizumab, about 3 cases [J].
Boudali, Julie ;
Hallak, Benjamin ;
Haeck, Marie ;
Sellier-Leclerc, Anne-Laure ;
Ulrich, Marc ;
Coppo, Paul ;
Tellier, Stephanie ;
Provot, Francois .
JOURNAL OF NEPHROLOGY, 2022, 35 (02) :653-656
[49]   Immune-mediated thrombotic thrombocytopenic purpura in childhood treated by caplacizumab, about 3 cases [J].
Julie Boudali ;
Benjamin Hallak ;
Marie Haeck ;
Anne-Laure Sellier-Leclerc ;
Marc Ulrich ;
Paul Coppo ;
Stéphanie Tellier ;
François Provôt .
Journal of Nephrology, 2022, 35 :653-656
[50]   Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura [J].
Voelker, Linus A. ;
Kaufeld, Jessica ;
Balduin, Gesa ;
Merkel, Lena ;
Kuehne, Lucas ;
Eichenauer, Dennis A. ;
Osterholt, Thomas ;
Haegele, Holger ;
Kann, Martin ;
Grundmann, Franziska ;
Kolbrink, Benedikt ;
Schulte, Kevin ;
Gaeckler, Anja ;
Kribben, Andreas ;
Boss, Kristina ;
Potthoff, Sebastian A. ;
Rump, Lars C. ;
Schmidt, Tilman ;
Muehlfeld, Anja S. ;
Schulmann, Karsten ;
Hermann, Matthias ;
Gaedeke, Jens ;
Sauerland, Kristin ;
Bramstedt, Joern ;
Hinkel, Ulrich P. ;
Miesbach, Wolfgang ;
Bauer, Frederic ;
Westhoff, Timm H. ;
Bruck, Heike ;
Buxhofer-Ausch, Veronika ;
Mueller, Tobias J. ;
Wendt, Ralph ;
Harth, Ana ;
Schreiber, Adrian ;
Seelow, Evelyn ;
Toelle, Markus ;
Gohlisch, Christopher ;
Bieringer, Markus ;
Geuther, Gesa ;
Jabs, Wolfram J. ;
Fischereder, Michael ;
von Bergwelt-Baildon, Anke ;
Schoenermarck, Ulf ;
Knoebl, Paul ;
Menne, Jan ;
Brinkkoetter, Paul T. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (03) :559-572